- 4201. Ad5CMV
- [A recombinant replication-deficient serotype 5 adenovirus. Containing an expression cassette consisting of the human cytomegalovirus (CMV) promoter and the simian virus 40 (SV40) polyadenylation signal, Ad5CMV is used as a transfer vector for inserting genes of interest into target cells for expression. (NCI04) ( NCI )] (UMLS (NCI) C1510774) =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 4251. Additional information
- (UMLS (HL7) C1546922) =Temporal Concept =Report timing;
|
- 4202. Ad5CMV p53 Gene
- [A replication-defective adenoviral-CMV vector that encodes a wild-type p53 gene. Ad5CMV-p53 induces tumor cells that have been transfected with the vector to produce wild-type p53, a tumor suppressor gene that is deleted or mutated in a significant number of cancers. In transfected tumor cells, the wild-type p-53 gene product exerts an antitumor effect by blocking cell cycle progression at the G1/S regulation point, activating DNA repair proteins in the presence of DNA damage, and initiating apoptosis when DNA damage is irreparable. (NCI04) ( NCI )] (UMLS (NCI) C0678021) =Pharmacologic Substance
| - 4252. additional locator
- [This can be a unit designator, such as apartment number, suite number, or floor. There may be several unit designators in an address (e.g., "3rd floor, Appt. 342"). This can also be a designator pointing away from the location, rather than specifying a smaller location within some larger one (e.g., Dutch "t.o." means "opposite to" for house boats located across the street facing houses). ( HL7V3.0 )] (UMLS (HL7) C1550716) =Idea or Concept =AddressPartType;
=unit designator;
unit identifier;
|
- 4203. Ad5CMV-p53 gene/Cisplatin/Fluorouracil
- (UMLS (NCI) C1134689) =Therapeutic or Preventive Procedure
| - 4253. Additional payment for service not provided by Medicare
- (UMLS (HL7) C1547455) =Intellectual Product =OCE Edit Code;
|
- 4204. Ad5CMV-p53 gene/Docetaxel
- (UMLS (NCI) C1134690) =Therapeutic or Preventive Procedure
| - 4254. Additional tissue required
- (UMLS (HL7) C1547221) =Intellectual Product =Tissue Type Code;
|
- 4205. Ad5CMV-p53 Gene/Docetaxel/Doxorubicin
- (UMLS (NCI) C1327753) =Therapeutic or Preventive Procedure ;
| - 4255. Additional X Chromosome
- (UMLS (NCI) C1510777) =Cell or Molecular Dysfunction
|
- 4206. ADA
- [Adenosine deaminase catalyzes the hydrolysis of adenosine to inosine. ADA deficiency causes one form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins. (LocusLink) ( NCI )] (UMLS (NCI) C0001457) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 4256. Additive
- (UMLS (HL7) C1549547) =Idea or Concept =RX Component Type;
|
- 4207. ADA
- [This gene is involved in nucleotide metabolism and cellular immunity. ( NCI )] (UMLS (NCI) C1412179) ADA Gene;
Adenosine Deaminase Gene =Gene or Genome ;
| - 4257. additive
- [A substance that is added to a system or compound to improve its characteristics. ( NCI )] (UMLS (HL7) C1550602) =Substance =ingredient;
|
- 4208. ADA Inhibitor
- [Substances that inhibit Adenosine Deaminase, an enzyme involved with purine metabolism. ( NCI )] (UMLS (NCI) C1373051) Adenosine Deaminase Inhibitor;
Adenosine Deaminase Inhibitors;
=Pharmacologic Substance ;
=Inhibitors, Nucleic Acid Synthesis;
| - 4258. additive, non-propagating
- [The association adds to the existing context associated with the Act, but will not propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Non-Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts for the purpose of this Act. However only the previously propagated authors will propagate to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552005) =Idea or Concept =ContextControlAdditive;
ContextControlNonPropagating |
- 4209. ADA Transduced T Cell
- [T cells harvested from a patient with adenosine deaminase (ADA) deficiency and transduced with a vector containing the gene for ADA. ADA catalyzes the hydrolysis of adenosine to inosine; ADA deficiency causes a form of severe combined immunodeficiency (SCID). Following genetic modification, the T cells are returned to the patient, where they produce functional ADA. ADA-transduced T cells have been shown to improve immune function in individuals with ADA deficiency. (NCI04) ( NCI )] (UMLS (NCI) C1510684) =Cell ;
| - 4259. additive, propagating
- [The association adds to the existing context associated with the Act, and will propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts, and will itself propagate with the other authors to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552003) =Idea or Concept =ContextControlAdditive;
ContextControlPropagating |
- 4210. Adalat
- (UMLS (NCI) C0590658) =Organic Chemical; Pharmacologic Substance
| - 4260. Additive/Preservative
- (UMLS (HL7) C1547765) =Biomedical or Dental Material =HL7 Vocabulary Version 2.5;
=ACETIC ACID;
Polydesis;
Potassium/K EDTA;
Potassium Oxalate;
FLUORIDE (AS SODIUM FLUORIDE);
HEPARIN SODIUM;
fibrinogenase;
Thymol;
toluene;
Bouin's solution;
nitric acid;
Phenol;
ACD Solution A;
Sodium Fluoride 10 MG;
ACD Solution B;
Amies transport medium;
Bacterial Transport medium;
Buffered 10% formalin;
Borate Boric Acid;
Buffered skim milk;
3.2% Citrate;
3.8% Citrate;
Carson's Modified 10% formalin;
Cary Blair Medium;
Chlamydia transport medium;
CTAD (this should be spelled out if not universally understood);
Potassium/K EDTA 15%;
Potassium/K EDTA 7.5%;
Sodium/Na EDTA;
Enteric bacteria transport medium;
Enteric plus;
10% Formalin;
"Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products)"
;Sodium Fluoride, 100mg;
6N HCL;
Ammonium heparin;
Lithium/Li Heparin;
Jones Kendrick Medium;
Karnovsky's fixative;
Lithium iodoacetate;
M4;
M4-RT;
M5;
Michel's transport medium;
MMD transport medium;
Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride;
Pages's Saline;
Reagan Lowe Medium;
Siliceous earth, 12 mg;
SPS(this should be spelled out if not universally understood);
Serum Separator Tube (Polymer Gel);
Stuart transport medium;
Thyoglycollate broth;
Ureaplasma transport medium;
Viral Transport medium;
Buffered Citrate (Westergren Sedimentation Rate);
None |
- 4211. ADAM Family Gene
- [ADAMs (A Disintegrin and Metalloproteinase Domain) are membrane-anchored proteases that regulate cell behavior by proteolytically modifying the cell surface and extracellular matrix. Currently, the ADAM family has 29 members, although the function of most ADAM gene products is unknown. The ADAM gene products with known functions act in a highly diverse set of biological processes, including fertilization, neurogenesis, myogenesis, embryonic TGF-alpha release and the inflammatory response. (from J Cell Biol 2002;159:893-902 and NCI) ( NCI )] (UMLS (NCI) C1332022) =Gene or Genome ;
| - 4261. Address
- (UMLS (HL7) C1547327) =Intellectual Product =Value type;
|
- 4212. ADAM Family Protein
- [The ADAM family consists of transmembrane proteins that contain a disintegrin and metalloprotease domain. By virtue of these domains they have the potent for both cell adhesion and protease activities. Currently, the ADAM family has 29 membranes, although the function of most ADAM gene products is unknown. The ADAM gene products with known functions act in a highly diverse set of biological processes, including fertilization, neurogenesis, myogenesis, embryonic TGF-alpha release and the inflammatory response. ( NCI )] (UMLS (NCI) C1332023) =Amino Acid, Peptide, or Protein; Enzyme
| - 4262. Address
- (UMLS (HL7) C1578437) =Intellectual Product =Data type;
|
- 4213. ADAM Type Metalloprotease Domain
- [ADAMs are transmembrane proteins containing both a disintegrin and a metalloprotease domain. Two thirds of the proteins with an ADAM type metalloprotease domain also contain the zinc protease pattern which locates the active site of these proteases. As they contain an adhesion domain and a protease domain, ADAM proteins potentially have both cell adhesion and protease activities. They play a role in various biological processes, including fertilization, neurogenesis, myogenesis, embryonic TGF-alpha release and inflammatory response. In ADAMTS proteins, a closely related family of proteases, the metalloprotease and disintegrin domains are flanked by thrombospondin type I (TSP1) repeat. ADAMTS proteins are soluble, extracellular matrix proteases. (From InterPro IPR001590) ( NCI )] (UMLS (NCI) C1510683) =Amino Acid Sequence ;
| - 4263. Address
- [For attributes representing the location at which an organization, person, or item may be found or reached. ( HL7V3.0 )] (UMLS (HL7) C1578436) =Intellectual Product =MDFAttributeType;
|
- 4214. adamantane
- [A tricyclo bridged hydrocarbon. ( MSH )] (UMLS (CSP) C0001392) =Organic Chemical
| - 4264. Address Part
- (UMLS (HL7) C1552678) =Idea or Concept =Character;
|
- 4215. Adamantinoid Basal Cell Carcinoma
- (UMLS (NCI) C1304295) Skin Adamantinoid Basal Cell Carcinoma;
Skin Adamantinoid Basal Cell Epithelioma;
=Neoplastic Process | - 4265. Address type
- (UMLS (HL7) C1547607) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Firm/Business;
Bad address;
Birth delivery location (address where birth occurred);
Residence at birth (home address at time of birth);
Current Or Temporary;
Country Of Origin;
Home;
Legal Address;
Mailing;
Birth (nee) (birth address, not otherwise specified);
Office;
Permanent;
Registry home. Refers to the information system, typically managed by a public health agency, that stores patient information such as immunization histories or cancer data, regardless of where the patient obtains services. |
- 4216. Adamantinoma
- [A locally aggressive, osteolytic neoplasm of the long bones, probably of epithelial origin and most often involving the TIBIA. ( MSH )] (UMLS (NCI) C1367554) =Neoplastic Process
| - 4266. AddressPartType
- [Discussion: The hierarchical nature of these concepts shows composition. E.g. "Street Name" is part of "Street Address Line" ( HL7V3.0 )] (UMLS (HL7) C1553795) =Intellectual Product =CodeSystem;
=postal code;
country;
state or province;
municipality;
additional locator;
county or parish;
street address line;
care of;
precinct;
building number suffix;
delivery address line;
census tract;
delimiter;
|
- 4217. Adamantinoma of Long Bones
- (UMLS (NCI) C0334556) =Neoplastic Process
| - 4267. AddressUse
- (UMLS (HL7) C1698330) =Spatial Concept ;
=PostalAddressUse;
=job site;
home address;
temporary address;
birthplace |
- 4218. Adamantinomatous Craniopharyngioma
- [A craniopharyngioma consisting of broad strands, cords and bridges of a multistratified squamous epithelium with peripheral palisading of nuclei. Diagnostic features include nodules of compact 'wet' keratin and dystrophic calcification. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0431129) =Neoplastic Process ;
| - 4268. adduct
- [compound produced by the mixing of two or more chemicals or a complex that forms when a chemical binds to a biological molecule, such as DNA or a protein. ( CSP )] (UMLS (CSP) C0596040) =Chemical Viewed Structurally ;
=chemical bond;
|
- 4219. Adams Laboratories
- [Adams Laboratories ( HL7V3.0 )] (UMLS (HL7) C1552882) =Health Care Related Organization =VaccineManufacturer;
| - 4269. ADDUCTOR TENOTOMY OF HIP
- [ ] (UMLS (ICD9CM) C0407093) =Therapeutic or Preventive Procedure
|
- 4220. Adams Laboratories, Inc.
- (UMLS (HL7) C1546859) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
| - 4270. ADE
- (UMLS (NCI) C0057163) =Therapeutic or Preventive Procedure
|
- 4221. ADAMTS
- [ ] (UMLS (CSP) C1328825) =Amino Acid, Peptide, or Protein; Enzyme
| - 4271. AdEERS
- [A Web application developed for the electronic submission of Expedited Reports to the NCI for serious and/or unexpected Adverse Events, deaths, and other events defined in the NCI Guidelines: Adverse Event Reporting Requirements for NCI Investigational Agents ( NCI )] (UMLS (NCI) C1510820) Adverse Drug Experience Reporting System;
Adverse Event Expedited Reporting System =Intellectual Product |
- 4222. Adanon
- (UMLS (NCI) C0699058) =Organic Chemical; Pharmacologic Substance
| - 4272. Adefovir Dipivoxil
- [An acyclic nucleotide adenine analogue with potent antiviral activity. Adefovir is activated in vivo to a diphosphate metabolite which is incorporated into viral DNA, leading to viral RNA-dependent DNA polymerase inhibition, DNA chain termination and impairment of viral replication. This agent inhibits the reverse transcriptases of hepatitis B, herpes and HIV viruses, induces natural killer cell activity, and stimulates endogenous interferon production. Viral resistance to adefovir develops at a slower rate compared to other antivirals. (NCI04) ( NCI )] (UMLS (NCI) C0540694) =Organic Chemical; Pharmacologic Substance ;
=9-(2-phophonylmethoxyethyl)adenine;
Unclassified Ingredients =ADEFOVIR DIPIVOXIL 10 MG |
- 4223. Adapter Molecule CRK
- [Containing SH2 and SH3 homology domains that interact with ABL, the tumor suppressor CRK protein appears to be a protein involved in signal transduction. (from OMIM 164762 and NCI) ( NCI )] (UMLS (NCI) C1451465) CRK;
CRK Protein;
P38;
Proto-Oncogene c-CRK =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 4273. Adelaide River virus
- [ ] (UMLS (CSP) C0599348) =Virus ;
|
- 4224. adapter protein
- [ ] (UMLS (CSP) C0599697) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 4274. adenase
- [ ] (UMLS (CSP) C0050739) =Amino Acid, Peptide, or Protein; Enzyme =aminohydrolase;
|
- 4225. Adaptor Protein
- [A class of signaling pathway proteins that function to mediate the coupling of multiple cell surface receptors to downstream signaling pathways in the regulation of various cellular functions. (from Oncogene 2001;20:6315-21) ( NCI )] (UMLS (NCI) C1135629) Adaptor Signaling Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 4275. adenine analog
- [chemical compound with a structure similar to that of the purine base adenine capable of base pairing and base substitutions. ( CSP )] (UMLS (CSP) C0596041) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =purine analog;
=9-(2-phophonylmethoxyethyl)adenine;
|
- 4226. Adaptor Protein Containing PH and SH2 Domains
- [Encoded by human APS Gene, 85 kD APS Protein appears to be found in spleen, prostate, testis, uterus, small intestine, skeletal muscle, and peripheral blood leukocytes. The 632-amino acid adaptor protein contains a PH domain, a SH2 domain, and a C-terminal tyrosine phosphorylation site. APS is structurally similar to the T-cell adaptor protein/signal transducer LNK and is tyrosine-phosphorylated after BCR cross-linking. APS associates with SHC regardless of BCR stimulation and with GRB2 after BCR stimulation. (OMIM and NCI) ( NCI )] (UMLS (NCI) C1449108) Adaptor Protein with Pleckstrin Homology and SRC Homology 2 Domains;
APS;
APS Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 4276. adenine nucleoside
- [purine base adenine attached to a ribose or deoxyribose. ( CSP )] (UMLS (CSP) C0596042) =Nucleic Acid, Nucleoside, or Nucleotide ;
=purine nucleoside;
=adenosine;
2-Fluoro-9-beta-arabinofuranosyladenine;
deoxyadenosine;
|
- 4227. Adaptor Protein Gene
- [A class of genes that encode signaling pathway proteins that function to mediate the coupling of multiple cell surface receptors to downstream signaling pathways in the regulation of various cellular functions. (from Oncogene 2001;20:6315-21) ( NCI )] (UMLS (NCI) C1332163) Adaptor Signaling Protein Gene;
=Gene or Genome ;
| - 4277. adenine nucleotide
- [condensation product of adenosine and phosphoric acid; a nucleotide found among the hydrolysis products of all nucleic acids. ( CSP )] (UMLS (CSP) C0001413) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance; Biologically Active Substance
|
- 4228. Adaptor Protein with Pleckstrin Homology and SRC Homology 2 Domains Gene
- [This gene is involved in signal transduction and plays a role in insulin-mediated glucose uptake. ( NCI )] (UMLS (NCI) C1332107) APS;
SH2B Adaptor Protein 2 Gene;
SH2B2;
SH2B2 Gene =Gene or Genome ;
| - 4278. Adenine Nucleotide Translocator-1
- [Expressed in heart, kidney, liver, skeletal muscle by human SLC25A4 Gene (Mitochondrial Carrier Family), 298-aa 33-kDa homodimeric Adenine Nucleotide Translocator-1 is an integral membrane protein embedded asymmetrically in the inner mitochondrial membrane that catalyzes transmembrane exchange of ADP and ATP and determines the rate of ADP/ATP flux between mitochondrion and cytosol. Strongly similar to murine Ant1, ANT1 contains 3 solute carrier (Solcar) repeats and the signature RRRMMM motif of nucleotide carriers; six alpha helices form a compact transmembrane domain. Defects in SLC25A4 are a cause of PEO. ( NCI )] (UMLS (NCI) C1442881) ADP-ATP Translocase-1;
ANT;
ANT1;
Heart-Skeletal Muscle ADP-ATP Carrier Protein-T1;
Mitochondrial Adenine Nucleotide Translocator Solute Carrier Family 25 Member-4;
Skeletal Muscle Adenine Nucleotide Translocator-1;
T1 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 4229. ADCC
- [Antibody-dependent target cell killing by a killer cell. An antibody is directed to the target by antigen-binding arms and anchors to the killer cell by an Fc receptor. Antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IgG whose Fc portion is intact. The effector "killer" cell possesses Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ( NCI )] (UMLS (CSP) C0003272) =Cell Function ;
| - 4279. Adenine Nucleotide Translocator-3
- [Encoded by human SLC25A6 Gene (Mitochondrial Carrier Family), 298-aa 33-kDa homodimeric integral membrane protein Adenine Nucleotide Translocator-3 contains 3 Solcar repeats and plays a fundamental role in cellular energy metabolism by catalyzing ADP/ATP exchange across the inner mitochondrial membrane. ( NCI )] (UMLS (NCI) C0600151) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 4230. ADCC Assay
- [An assay based on Antibody-Dependent Cellular Cytotoxicity which involves the killing of a target cell by a killer cell by means of an antibody directed to the target by the antigen-binding arms and anchored to the killer cell via an Fc receptor. ( NCI )] (UMLS (NCI) C0201624) =Laboratory Procedure
| - 4280. adenine phosphoribosyltransferase
- [Human adenine phosphoribosyltransferase protein (179 aa, 19 kDa) is encoded by the human adenine phosphoribosyltransferase (APRT) gene. The cytoplasmic protein is primarily involved in an AMP purine salvage reaction that recycles adenine into nucleic acids by the formation of AMP from adenine and 5-phosphoribosyl-1-pyrophosphate. ( NCI )] (UMLS (CSP) C0001414) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 4231. ADCOMP
- (UMLS (NCI) C0279504) =Therapeutic or Preventive Procedure
| - 4281. Adenine Phosphoribosyltransferase Gene
- [This gene plays a role in the purine salvage pathway. ( NCI )] (UMLS (NCI) C1366623) APRT;
APRT Gene =Gene or Genome |
- 4232. ADCY9
- [This gene is involved in nucleotide metabolism and signal transduction. ( NCI )] (UMLS (NCI) C1332025) ADCY9 Gene;
Adenylate Cyclase 9 Gene;
=Gene or Genome ;
| - 4282. Adenitis
- [Inflammation of the lymph nodes. ( MSH )] (UMLS (NCI) C0024205) =Disease or Syndrome ;
=adenopathy;
=Cat-scratch disease;
MESENTERIC LYMPHADENITIS;
Lymph Node Tuberculosis;
Histiocytic Necrotizing Lymphadenitis |
- 4233. ADCY9
- [Adenylyl cyclases are membrane-associated enzymes of the lyase class that are expressed in most human tissues. These enzymes catalyze the formation of cyclic AMP and pyrophosphate from ATP and are regulated by a family of G protein-coupled receptors, protein kinases, and calcium. Adenylyl cyclase is encoded by the ADCY9 gene and widely distributed. It is stimulated by beta-adrenergic receptor activation but is insensitive to forskolin, calcium, and somatostatin. It may play a fundamental role in situations where fine interplay between intracellular Ca(2+) and cAMP determines the cellular function. It also may be a physiologically relevant docking site for calcineurin. ( NCI )] (UMLS (NCI) C1382029) Adenyl Cyclase 9;
Adenylate Cyclase;
Adenylyl Cyclase 9;
Adenylylcyclase 9;
ATP Pyrophosphate-Lyase;
EC 4.6.1.1 =Amino Acid, Peptide, or Protein; Enzyme | - 4283. adeno associated virus group
- [replication is dependent on a helper adenovirus; multiplies in cells which support adenovirus replication in many species of host. ( CSP )] (UMLS (CSP) C0001417) =Virus
|
- 4234. ADD
- (UMLS (HL7) C1548443) =Intellectual Product =Problem/goal action code;
| - 4284. Adenoacanthoma
- [An invasive adenocarcinoma characterized by the presence of focal or extensive transformation of malignant glandular cells to squamous epithelial cells. ( NCI )] (UMLS (NCI) C0334393) =Neoplastic Process
|
- 4235. Add ordered tests to the existing specimen
- (UMLS (HL7) C1546519) =Intellectual Product =Specimen Action Code;
| - 4285. Adenoacanthoma of Breast
- (UMLS (NCI) C1332613) Adenoacanthoma of the Breast;
Adenocarcinoma of Breast with Squamous Metaplasia;
Adenocarcinoma of the Breast with Squamous Metaplasia;
Breast Adenoacanthoma;
Breast Adenocarcinoma with Squamous Metaplasia =Neoplastic Process ;
|
- 4236. Add personnel record
- (UMLS (HL7) C1548071) =Idea or Concept =Message type;
| - 4286. Adenocanthoma of Endometrium
- [An endometrioid adenocarcinoma of the endometrium showing squamous differentiation. — 2004 ( NCI )] (UMLS (NCI) C0279763) =Neoplastic Process
|
- 4237. Add record to master file
- (UMLS (HL7) C1549606) =Intellectual Product =Record-level event code;
| - 4287. Adenocarcinofibroma
- (UMLS (NCI) C1510778) Malignant Adenofibroma;
=Neoplastic Process |
- 4238. ADD-Type Zinc-Finger
- (UMLS (NCI) C1510685) =Amino Acid Sequence ;
| - 4288. Adenocarcinoid Neoplasm
- [A malignant epithelial neoplasm composed of a mixture of neuroendocrine cells with morphologic and immunohistochemical characteristics of carcinoid tumor and malignant glandular cells. ( NCI )] (UMLS (NCI) C0334302) =Neoplastic Process
|
- 4239. Add/change billing account
- (UMLS (HL7) C1548013) =Idea or Concept =Message type;
| - 4289. Adenocarcinoid Neoplasm of Appendix
- [A carcinoma arising from a pre-existing goblet cell carcinoid tumor of the appendix. The appendiceal mucosal epithelium is not involved by the neoplastic process. ( NCI )] (UMLS (NCI) C1332164) Adenocarcinoid Neoplasm of the Appendix;
Adenocarcinoid Tumor of Appendix;
Adenocarcinoid Tumor of the Appendix;
Appendiceal Adenocarcinoid;
Appendiceal Adenocarcinoid Neoplasm;
Appendiceal Adenocarcinoid Tumor;
Appendix Adenocarcinoid Neoplasm;
Appendix Adenocarcinoid Tumor;
Appendix Glandular Carcinoid Tumor;
Appendix Mixed Carcinoid-Adenocarcinoma =Neoplastic Process ;
|
- 4240. Add/Insert
- (UMLS (HL7) C1548565) =Intellectual Product =Action Code;
◊ (UMLS (HL7) C1549771) Intellectual Product Segment action code; | - 4290. adenocarcinoma
- [carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures. ( CSP )] (UMLS (CSP) C0001418) =Neoplastic Process
|
- 4241. Added Concurrent Therapy
- [Instituted an additional therapy to mitigate potential negative effects ( HL7V3.0 )] (UMLS (HL7) C1555298) =Intellectual Product =Other Action Taken;
| - 4291. Adenocarcinoma and Small Cell Carcinoma of Lung
- [A lung carcinoma characterized by a combination of small cell carcinoma and adenocarcinoma. (NCI05) ( NCI )] (UMLS (NCI) C1332165) Adenocarcinoma and Small Cell Carcinoma of the Lung;
Adenocarcinoma and Small Cell Lung Carcinoma;
Combined Small Cell Lung Carcinoma and Lung Adenocarcinoma;
=Neoplastic Process ;
|
- 4242. Addendum
- [An appendage to an existing document that contains supplemental information. The parent document remains content is unaltered. ( NCI )] (UMLS (NCI) C1510776) =Intellectual Product
| - 4292. Adenocarcinoma Arising in Barrett's Mucosa
- [An adenocarcinoma arising from Barrett metaplastic epithelium in the esophagus. There is evidence supporting the idea that the Barrett adenocarcinomas develop through a stepwise progression through intestinal metaplastic epithelium to epithelial dysplasia to malignancy. Adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. In terms of grading, they are well or moderately differentiated adenocarcinomas. — 2002 ( NCI )] (UMLS (NCI) C1332460) Barrett Adenocarcinoma;
Barrett's Adenocarcinoma;
=Neoplastic Process ;
|
- 4243. Adderall
- (UMLS (NCI) C0290795) =Organic Chemical; Pharmacologic Substance ;
| - 4293. Adenocarcinoma Cell
- (UMLS (NCI) C1510779) Malignant Glandular Cell;
=Cell |
- 4244. Adderall XR
- (UMLS (NCI) C1170024) Adderall-XR =Organic Chemical; Pharmacologic Substance ;
| - 4294. Adenocarcinoma Cell with Eosinophilic Granular Cytoplasm
- (UMLS (NCI) C1510780) =Cell
|
- 4245. ADDH
- [A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV) ( MSH )] (UMLS (CSP) C1263846) ADHD;
ADHD (attention deficit hyperactivity disorder);
Attention deficit disorder of childhood with hyperactivity;
Attention Deficit Disorder with Hyperactivity;
attention deficit hyperactivity disorder;
ATTN DEFICIT W HYPERACT;
HYPERKINETIC SYND NOS;
Hyperkinetic syndrome of childhood;
Unspecified hyperkinetic syndrome of childhood =Mental or Behavioral Dysfunction =Attention Deficit and Disruptive Behavior Disorders;
| - 4295. Adenocarcinoma Cell with Intranuclear Inclusion
- (UMLS (NCI) C1510781) =Cell
|
- 4246. addiction
- [Uncontrollable craving, seeking, and use of a substance such as a drug or alcohol. ( NCI )] (UMLS (NCI) C0085281) =Mental or Behavioral Dysfunction
| - 4296. Adenocarcinoma Cell with Perinuclear Clearing
- (UMLS (NCI) C1510782) =Cell
|
- 4247. Addiction (Substance Use Disorder)
- (UMLS (HL7) C1555895) =Intellectual Product =Counselor;
◊ (UMLS (HL7) C1555901) Intellectual Product Psychologist; ◊ (UMLS (HL7) C1555965) Intellectual Product Registered Nurse; | - 4297. Adenocarcinoma in Adenomatous Polyp
- [A non-invasive or invasive adenocarcinoma arising from the neoplastic glandular cells in an adenomatous polyp. ( NCI )] (UMLS (NCI) C1321861) =Neoplastic Process ;
|
- 4248. Addiction Medicine
- (UMLS (HL7) C1555726) =Intellectual Product =Anesthesiology;
◊ (UMLS (HL7) C1555744) Intellectual Product Family Practice; ◊ (UMLS (HL7) C1555751) Intellectual Product Internal Medicine; ◊ (UMLS (HL7) C1555861) Intellectual Product Psychiatry & Neurology; | - 4298. Adenocarcinoma in Adenomatous Polyposis Coli
- [Adenocarcinomas developing in colorectal adenomas in patients with a history of adenomatous polyposis coli. The mean age of development of adenocarcinoma is about 40 years. ( NCI )] (UMLS (NCI) C0334293) =Neoplastic Process
|
- 4249. Addiction Psychiatry
- (UMLS (HL7) C1555862) =Intellectual Product =Psychiatry & Neurology;
| - 4299. Adenocarcinoma in Multiple Adenomatous Polyps
- [Adenocarcinomas developing in gastrointestinal tract adenomas in patients with multiple adenomatous polyps. ( NCI )] (UMLS (NCI) C0334295) =Neoplastic Process
|
- 4250. Addison's disease
- [disease characterized by hypotension, weight loss, anorexia, weakness, and sometimes a bronze-like melanotic hyperpigmentation of the skin; due to tuberculosis or autoimmune induced disease (hypofunction) of the adrenal glands that results in deficiency of aldosterone and cortisol. ( CSP )] (UMLS (CSP) C0001403) =Disease or Syndrome
| - 4300. Adenocarcinoma In Situ
- [A lesion in which the normally situated glands are partially or completely replaced by atypical cells with malignant characteristics. ( NCI )] (UMLS (NCI) C0334276) =Neoplastic Process
|
home 
Armenian-English 
top